Search

Your search keyword '"Sztriha, L"' showing total 402 results

Search Constraints

Start Over You searched for: Author "Sztriha, L" Remove constraint Author: "Sztriha, L"
402 results on '"Sztriha, L"'

Search Results

1. Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

2. Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes

3. Predicting atrial fibrillation risk following embolic stroke of unknown source using cardiac magnetic resonance imaging

4. Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

5. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

6. Distinguishing the four genetic causes of Jouberts syndrome-related disorders

7. Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis

8. Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis

9. Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C

10. Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C

28. Rivaroxaban for stroke prevention after embolic stroke of undetermined source

30. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial

31. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

32. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

34. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

35. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

38. Jouberts Syndrome: extension of genetic linkage to chromosome 9q34.3

39. Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III

42. Phenotypic spectrum and prevalence of INPP5E mutations in Joubert Syndrome and related disorders

43. A single human ciliopathy locus highlights the evolutionary dynamics of non-duplicated but adjacent genes

44. Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia

45. Congenitalinsensitivity to pain with anhidrosis: novel mutations in the TRKA (NTRK1) geneencoding a high-affinity receptor for nerve growth factor

47. Clinical presentation and outcome in a series of 88 patients with the cblC defect

48. Mutations in the cilia gene ARL13B lead to the classical form of Joubert syndrome

49. CEP290 mutations are frequently identified in the oculo-renal form of Joubert syndrome-related disorders

50. CEP290 mutations are frequently identified in the oculo-renal form of Joubert syndrome-related disorders

Catalog

Books, media, physical & digital resources